© Copyright 2019 Doctors Without Borders (MSF) Southern Africa | MSF-SA Association | Southern Africa Medical Unit
Khayelitsha activity report 2001 - 2011
The Khayelitsha programme was the first in South Africa to provide antiretroviral therapy (ART) at primary care level in the public sector. It is also one of two pilot projects in the country to provide decentralized care for drug-resistant tuberculosis (DR-TB).
Patent barriers to medicine access in South Africa: A case for patent law reform
Over the past 15 years, HIV activists in South Africa have won significant victories to secure affordable access to antiretroviral (ARV) treatment through challenging patent monopolies. The cost of a first line ARV regimen in the country has dropped by 96% since 2000.